Hepion Pharmaceuticals (HEPA) Announces Passing of Key Safety Milestone in Phase 2b ‘ASCEND-NASH’ Trial...

Completion of Enrollment Remains on Track for Q1, 2024 "While we recently had fireworks, we could be looking at...

Hepion (HEPA) Back in the Spotlight, Gains 230% in May.

Hepion (HEPA) Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and...

And We Have a $26.4 Billion Winning Trifecta!

THREE PREVIOUS WINNERS* Immunomedics (IMMU) $3 to $87 up 2,800%, a gain of $20.7 billion. Acquired...

Revive Therapeutics (RVVTF) Enters the Danger Zone.

What Danger You Ask? Danger #1, the FDA doesn't like the data, and you own the stock.

Report on Citius Pharma (CTXR): North Shore Research Issues a $10 Price Target, a...

We're Up 181% on Citius Pharma (CTXR), Despite its Being Well Below it's Recent High of $4.30. We Now Have Two $10...

Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy.

Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy I/ONTAK (E7777) for the Treatment of Persistent or...
Biotech Stock Review

Citius Pharma (CTXR) Flexes Muscle in Business Update. Remains Our Top Idea.

Added to Watch List November 2019 @$0.55. Named Our Top Idea in 2020 @$1.02.Remains Our Top Idea in 2021...

Hapbee (HAPB) Expands Leadership Team to Support Aggressive Growth Strategy

VANCOUVER, BC, Aug. 6, 2021 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) ("Hapbee" or the "Company"), the leading wearable, wellness technology company has...

Citius Pharma (CTXR) $2.15. Price Target of $8.00 Maintained, Post Safety and Efficacy Review.

Investment Banker Buy Rating Maintained: DSMB Gives the Thumbs Up – Data in Early 2022. CITIUS NEWS ARCHIVE

Preventing Type I Diabetes. Here’s How Provention (PRVB) Works.

Here's How Provention's Treatment Works. Interview With an Actual Provention Bio (PRVB) Clinical Trial Participant.

Latest article

Gold prices plunge in biggest one-day drop in years. Is the record rally over?...

Easing anxieties over Trump’s tariff policies and the Fed chair’s fate spark gold’s worst daily decline since 2021 Gold...

Gold Price Sets New Intraday Record Above $3,500 (WSJ)

Gold hit another record Tuesday, then faded a bit in afternoon trading. The most actively traded futures contracts surged...

Gold Surges to a Record Above $3,400 as Trump threatens Fed Independence (CNBC)

Gold prices broke $3,400 on Monday, hitting a new record as President Donald Trump’s threats against the...